Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Don Miller who wrote (4263)	3/9/2000 1:10:00 PM
From: rkrw	Read Replies (2) of 10280

More important than hyping abstracts is getting drugs on the market. DCL will be the third drug approval for Sepracor. So while some (pitiable) investors long for hype, Sepracor continues building a formidable pipeline with powerful future earnings potential. By my count, Sepracor and its partners should be at around 10 drugs in the clinic. norastemizole ditropan formoterol meridia(+) meridia(-) zopiclone prozac propulsid zyrtec DCL Xopenex-follow ons.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next